arrow
A

Annette M. Staiger

Robert Bosch Hospital
H指数:28
被引数:4,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images

利用H&E全切片图像进行弥漫性大B细胞淋巴瘤预后评估的AI

2026-09-010
OAAI
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models

患者来源的3D胃肠道间质瘤模型作为替代体内小鼠模型的可行性

2026-03-030
OAAI
Integration of high-throughput proteomic data and complementary omics layers with PriOmics

利用PriOmics整合高通量蛋白质组学数据及互补的组学数据

2026-01-010
PRE
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP

Perforin 1 A91V胚系背景对接受R-CHOP治疗的侵袭性B-NHL患者的影响

2025-12-070
OA
Cyclin D1 rearranged diffuse large B-cell lymphoma—an evolving concept

Cyclin D1 rearranged diffuse large B-cell lymphoma——一个不断发展的概念

Leukemia
IF13.4
2025-11-070
PRE
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA

弥漫大B细胞淋巴瘤的年龄和性别特异性分子特征:来自DSHNHL/GLA临床 trial 的结果

2025-03-070
OAAI
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration

MicroRNA在11q畸变高级别b细胞淋巴瘤中的表达

2025-01-230
OAAI
Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma
LEUKEMIA
IF13.4
2023-08-303
OAAI
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
LEUKEMIA
IF13.4
2023-08-105
OAAI
Molecular profiling of EBV associated diffuse large B-cell lymphoma
LEUKEMIA
IF13.4
2023-01-0529
OAAI
Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas
2022-09-015
OAAI
PARP14 is a novel target in STAT6 mutant follicular lymphoma

PARP14是STAT6突变型滤泡性淋巴瘤的新靶点

LEUKEMIA
IF13.4
2022-07-1810
OAAI
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
2021-08-3129
OAAI
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

弥漫性大b细胞淋巴瘤hla-i缺失和免疫逃逸的遗传机制

2021-05-2845
OAAI
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
2021-04-0121
PREAI
Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours
2020-12-255
PREAI
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
2020-09-175
OAAI